APIs pour la recherche et les impuretés

GSK-2793660 is a potent and selective analog of a human protein kinase inhibitor that has been shown to induce apoptosis in cancer cells. It is a medicinal compound that inhibits the activity of kinases, which are enzymes involved in cell signaling pathways. GSK-2793660 has demonstrated anticancer activity in preclinical studies, particularly against Chinese hamster ovary (CHO) tumor models. This inhibitor has also been found in urine samples from cancer patients, indicating its potential as a diagnostic tool for cancer. Its ability to selectively target specific kinases makes it a promising candidate for the development of new cancer therapies.

Duloxetine is a drug product that belongs to the class of drugs known as selective serotonin and norepinephrine reuptake inhibitors. Duloxetine is a metabolite of duloxetine phenyl carbamate, which is an impurity standard for HPLC analysis. Duloxetine has been shown to inhibit the metabolism of serotonin and norepinephrine in the brain, leading to increased amounts of these neurotransmitters. This medication has been studied in niche populations such as those with depression and diabetic neuropathy. Duloxetine also has high purity standards, meeting the requirements of pharmacopoeia.

2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is an analytical standard used as a reference compound in the drug development process. It is also used as a pharmacopoeia standard and a custom synthesis. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is synthesized from natural or synthetic sources. This product has been shown to have an impurity level of less than 1%. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is not known to be metabolized by the human body and does not produce any metabolites.

Please enquire for more information about 4-Acetyl-3,4-dihydro-2H-pyrido[3,2-b]oxazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Roxithromycin impurity H is an analytical standard for Roxithromycin. It is a metabolite that has been identified in human urine and bile samples as well as in rat plasma following oral administration of Roxithromycin. It is also a byproduct of the synthesis of Roxithromycin, which can be eliminated through purification steps. This compound has not yet been evaluated in humans or animals, but it may cause adverse effects such as gastrointestinal disturbances, headache, or hepatotoxicity.

Hydroxymethyl tolperisone is a medicinal compound that has been identified as a kinase inhibitor with potential anticancer properties. It has shown promising results in inhibiting the growth of leukemia cells and tumor cell lines in human studies. Hydroxymethyl tolperisone works by interfering with protein synthesis, disrupting the cell cycle, and inducing apoptosis in cancer cells. This compound has also been found to be effective against various types of cancer, including breast, lung, and colon cancer. Hydroxymethyl tolperisone is an analog of tolperisone, a muscle relaxant that is excreted primarily through urine. The use of this compound as an anticancer agent is still under investigation, but it holds great promise for the future of cancer treatment.